{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:07:53Z","timestamp":1793351273836,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.euf.2025.06.009","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:07:31Z","timestamp":1754406451000},"page":"978-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Urinary Tumor DNA\u2013based Liquid Biopsy in Bladder Cancer Management: A Systematic Review"],"prefix":"10.1016","volume":"11","author":[{"given":"Joanne","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lopez-Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cimadamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinchita","family":"Roy-Chowdhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Golijanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-5293","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2025.06.009_b0005","doi-asserted-by":"crossref","first-page":"04109","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J Glob Health"},{"key":"10.1016\/j.euf.2025.06.009_b0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euf.2025.06.009_b0015","doi-asserted-by":"crossref","first-page":"16578","DOI":"10.3390\/ijms242316578","article-title":"Tumor-agnostic circulating tumor DNA testing for monitoring muscle-invasive bladder cancer","volume":"24","author":"Carrasco","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.euf.2025.06.009_b0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12885-022-09733-8","article-title":"Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor","volume":"22","author":"Jeong","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euf.2025.06.009_b0025","first-page":"417","article-title":"Comparison of bladder ultrasonographic and rigid cystoscopic findings in patients with hematuria","volume":"10","author":"Mostafaloo","year":"2019","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.euf.2025.06.009_b0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cncy.21327","article-title":"Evaluation of UroVysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation","volume":"121","author":"Dimashkieh","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.euf.2025.06.009_b0035","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: a comprehensive review of the published literature","volume":"21","author":"Botteman","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.euf.2025.06.009_b0040","article-title":"Emerging roles of urine-based tumor DNA analysis in bladder cancer management","volume":"4","author":"Chaudhuri","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0045","first-page":"405","article-title":"Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment","volume":"18","author":"Szarvas","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.euf.2025.06.009_b0050","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euf.2025.06.009_b0055","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/bju.13186","article-title":"Novel fluorescence in situ hybridization-based definition of bacille Calmette-Gu\u00e9rin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies","volume":"117","author":"Kamat","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2025.06.009_b0060","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00345-014-1452-9","article-title":"Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?","volume":"33","author":"Seideman","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.06.009_b0065","doi-asserted-by":"crossref","first-page":"27.e1","DOI":"10.1016\/j.urolonc.2012.09.011","article-title":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0070","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1245\/s10434-016-5763-5","article-title":"Anticipatory positive urine tests for bladder cancer","volume":"24","author":"Gopalakrishna","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.06.009_b0080","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.3892\/ol.2017.5926","article-title":"Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma","volume":"13","author":"Lin","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.euf.2025.06.009_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4274\/uob.galenos.2024.2024.3.3","article-title":"Contemporary role of urine cytology in bladder cancer","volume":"23","author":"Kars","year":"2024","journal-title":"Bull Urooncol"},{"key":"10.1016\/j.euf.2025.06.009_b0090","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1002\/ctd2.183","article-title":"Recent development of urinary biomarkers for bladder cancer diagnosis and monitoring","volume":"3","author":"Zeng","year":"2023","journal-title":"Clin Transl Discov"},{"key":"10.1016\/j.euf.2025.06.009_b0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1878-0261.13530","article-title":"Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy","volume":"18","author":"Rac","year":"2024","journal-title":"Mol Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.06.009_b0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1464-4096.2001.01899.x","article-title":"The community-based morbidity of flexible cystoscopy","volume":"89","author":"Burke","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2025.06.009_b0110","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells1","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2025.06.009_b0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41585-023-00725-2","article-title":"Circulating and urinary tumour DNA in urothelial carcinoma\u2014upper tract, lower tract and metastatic disease","volume":"20","author":"Rose","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2025.06.009_b0120","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/ijms20112657","article-title":"DNA-methylation-based detection of urological cancer in urine: overview of biomarkers and considerations on biomarker design, source of DNA, and detection technologies","volume":"20","author":"Larsen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.euf.2025.06.009_b0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clinbiochem.2018.11.009","article-title":"Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer","volume":"64","author":"Stasik","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.euf.2025.06.009_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1525-1578(10)60497-7","article-title":"Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer","volume":"6","author":"Su","year":"2004","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.euf.2025.06.009_b0135","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1078-0432.CCR-22-3250","article-title":"Cell-free urine and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle-invasive bladder cancer","volume":"29","author":"Christensen","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2025.06.009_b0140","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3389\/fonc.2019.01266","article-title":"Urine biopsy-liquid gold for molecular detection and surveillance of bladder cancer","volume":"9","author":"Satyal","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0145","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ejhg.2015.281","article-title":"Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA","volume":"24","author":"Togneri","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.euf.2025.06.009_b0150","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/cancers12040859","article-title":"Comparative analysis of urine fractions for optimal bladder cancer detection using DNA methylation markers","volume":"12","author":"Hentschel","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euf.2025.06.009_b0155","series-title":"Advances in clinical chemistry","first-page":"265","article-title":"Biomarkers in muscle invasive bladder cancer","author":"Wilson","year":"2022"},{"key":"10.1016\/j.euf.2025.06.009_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115027","article-title":"Liquid biopsy in urothelial carcinoma: detection techniques and clinical applications","volume":"165","author":"Wu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.euf.2025.06.009_b0165","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.euf.2025.06.009_b0170","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1158\/1078-0432.CCR-23-0570","article-title":"Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk-prediction","volume":"29","author":"Salari","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2025.06.009_b0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eururo.2024.10.014","article-title":"Sensitive detection of urothelial cancer via high-volume urine DNA analysis","volume":"87","author":"Nikkola","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.06.009_b0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.euo.2022.03.005","article-title":"Highly sensitive and specific detection of bladder cancer via targeted ultra-deep sequencing of urinary DNA","volume":"6","author":"Ward","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0185","article-title":"Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy","volume":"7","author":"Springer","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.euf.2025.06.009_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102643","article-title":"Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: evidence from the Golestan Cohort Study","volume":"53","author":"Hosen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.euf.2025.06.009_b0195","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1148\/rg.2021200067","article-title":"Complications of ileal conduits after radical cystectomy: interventional radiologic management","volume":"41","author":"Kobayashi","year":"2020","journal-title":"RadioGraphics"},{"key":"10.1016\/j.euf.2025.06.009_b0200","article-title":"Urine biopsy as dynamic biomarker to enhance clinical staging of bladder cancer in radical cystectomy candidates","volume":"8","author":"Satyal","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0205","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/1078-0432.CCR-23-0513","article-title":"Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2025.06.009_b0210","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41375-024-02252-4","article-title":"Measurable residual disease (MRD)-testing in haematological and solid cancers","volume":"38","author":"Chen","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.euf.2025.06.009_b0215","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.euf.2025.06.009_b0220","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the bladder EpiCheck\u2122 methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0225","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/bjc.2017.210","article-title":"Noninvasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine","volume":"117","author":"Descotes","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euf.2025.06.009_b0230","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3389\/fgene.2019.01237","article-title":"Validation of a novel, sensitive, and specific urine-based test for recurrence surveillance of patients with non-muscle-invasive bladder cancer in a comprehensive multicenter study","volume":"10","author":"Batista","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.euf.2025.06.009_b0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.48083\/WJMB7232","article-title":"Utilizing cell-free urinary and plasma tumor DNA to predict pathologic stage at radical cystectomy","volume":"4","author":"Murthy","year":"2023","journal-title":"Soc Int Urol J"},{"key":"10.1016\/j.euf.2025.06.009_b0240","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/JU.0000000000001878","article-title":"Urinary molecular pathology for patients with newly diagnosed urothelial bladder cancer","volume":"206","author":"Zhang","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.06.009_b0245","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2022.09.008","article-title":"Elevated T-cell exhaustion and urinary tumor DNA levels are associated with bacillus Calmette-Gu\u00e9rin failure in patients with non\u2013muscle-invasive bladder cancer","volume":"82","author":"Strandgaard","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.06.009_b0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.48083\/EABM2528","article-title":"Urinary tumor DNA-based diagnosis and surveillance for nonmuscle-invasive bladder cancer\u2014current landscape and future directions","volume":"4","author":"Shiang","year":"2023","journal-title":"Soc Int Urol J"},{"key":"10.1016\/j.euf.2025.06.009_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116312","article-title":"Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer","volume":"173","author":"Fan","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.euf.2025.06.009_b0260","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1200\/JCO.23.00435","article-title":"Standardized definitions for efficacy end points in neoadjuvant breast cancer clinical trials: NeoSTEEP","volume":"41","author":"Litton","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.06.009_b0265","article-title":"Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: a cohort study","volume":"18","author":"Chauhan","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.euf.2025.06.009_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200906","article-title":"A protocol for urine collection and storage prior to DNA methylation analysis","volume":"13","author":"Bosschieter","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2025.06.009_bib271","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.urolonc.2024.01.025","article-title":"Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer","volume":"42","author":"Benderska-S\u00f6der","year":"2024","journal-title":"Urol. Oncol.: Seminars and Original Investigations"},{"key":"10.1016\/j.euf.2025.06.009_bib272","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.euo.2023.05.012","article-title":"Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review","volume":"7","author":"Crupi","year":"2024","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925001786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925001786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:12:30Z","timestamp":1765404750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456925001786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2405456925001786"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2025.06.009","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary Tumor DNA\u2013based Liquid Biopsy in Bladder Cancer Management: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2025.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}